KaloCyte moves to University of Maryland BioPark
A biotechnology company developing a synthetic blood product that could be used in trauma settings is joining the community at Baltimore's University of Maryland BioPark. KaloCyte,…
A biotechnology company developing a synthetic blood product that could be used in trauma settings is joining the community at Baltimore's University of Maryland BioPark. KaloCyte,…